Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death

Peer Review reports

Original Submission
8 Jul 2022	Submitted	Original manuscript
22 Aug 2022	Reviewed	Reviewer Report
11 Sep 2022	Reviewed	Reviewer Report
17 Sep 2022	Author responded	Author comments - Zhuoying Huang
Resubmission - Version 2
17 Sep 2022	Submitted	Manuscript version 2
22 Sep 2022	Reviewed	Reviewer Report
2 Oct 2022	Reviewed	Reviewer Report
10 Oct 2022	Author responded	Author comments - Zhuoying Huang
Resubmission - Version 3
10 Oct 2022	Submitted	Manuscript version 3
Publishing
13 Oct 2022	Editorially accepted
20 Oct 2022	Article published	10.1186/s12916-022-02606-8

Back to article page